<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abstract Over the past decade, the off-label use of biologic agents such as TNF-α <z:chebi fb="68" ids="48706">antagonists</z:chebi>, including infliximab and adalimumab, has improved the treatment armamentarium for refractory immune-mediated <z:hpo ids='HP_0000554'>uveitis</z:hpo>, with particular success in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease-associated <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Golimumab is a novel fully human anti-TNF-α monoclonal antibody that has been approved for the treatment of <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, psoriatic <z:hpo ids='HP_0001369'>arthritis</z:hpo>, and <z:e sem="disease" ids="C0038013" disease_type="Disease or Syndrome" abbrv="">ankylosing spondylitis</z:e>, with very promising results </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, the authors present the use of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GLM</z:e> in a case of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet <z:hpo ids='HP_0000554'>uveitis</z:hpo> refractory to other TNF-α blockers </plain></SENT>
<SENT sid="3" pm="."><plain>There are only two reports in the literature about the use of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GLM</z:e> in <z:hpo ids='HP_0000554'>uveitis</z:hpo>, describing four patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JIA</z:e>-associated <z:hpo ids='HP_0000554'>uveitis</z:hpo> and a case of idiopathic <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>To the authors' knowledge, this is the first report about the use of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GLM</z:e> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet <z:hpo ids='HP_0000554'>uveitis</z:hpo> </plain></SENT>
</text></document>